Aquilo Capital Management as of Sept. 30, 2021
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 14 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p Biotech Etf Tr Unit Put Option (XBI) | 22.8 | $126M | 1.0M | 125.71 | |
| Spero Therapeutics (SPRO) | 15.3 | $84M | 4.6M | 18.41 | |
| Blueprint Medicines (BPMC) | 9.7 | $54M | 522k | 102.81 | |
| Dicerna Pharmaceuticals | 9.0 | $50M | 2.5M | 20.16 | |
| Uniqure Nv SHS (QURE) | 7.7 | $42M | 1.3M | 32.01 | |
| Regenxbio Inc equity us cm (RGNX) | 6.4 | $35M | 839k | 41.92 | |
| Arrowhead Pharmaceuticals (ARWR) | 6.0 | $33M | 528k | 62.43 | |
| 4d Molecular Therapeutics In (FDMT) | 5.4 | $30M | 1.1M | 26.97 | |
| Arvinas Ord (ARVN) | 5.3 | $29M | 355k | 82.18 | |
| Magenta Therapeutics | 4.2 | $23M | 3.2M | 7.28 | |
| Amryt Pharma Sponsored Ads | 3.0 | $17M | 1.4M | 12.05 | |
| Pieris Pharmaceuticals (PIRS) | 3.0 | $17M | 3.2M | 5.17 | |
| Argenx Se Sponsored Adr (ARGX) | 1.2 | $6.7M | 22k | 301.98 | |
| Genmab A/s Sponsored Ads (GMAB) | 1.0 | $5.6M | 128k | 43.70 |
